Cerence (CRNC)

Cerence (CRNC) Income Statement


Cerence Income Statement

Last quarter (Q2 2023), Cerence's total revenue was $68.39M, a decrease of -20.73% from the same quarter last year. In Q2, Cerence's net income was $-26.09M. See Cerence’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
$ 299.24M$ 327.89M$ 387.18M$ 330.97M$ 303.31M$ 276.98M
Cost of Revenue
$ 28.57M$ -97.17M$ 101.07M$ 107.85M$ 99.34M$ 82.96M
Gross Profit
$ 218.30M$ 230.72M$ 286.11M$ 223.12M$ 203.97M$ 194.02M
Operating Expense
$ 101.67M$ -415.07M$ 220.42M$ 184.23M$ 167.77M$ 140.22M
Operating Income
$ 5.89M$ 29.38M$ 65.69M$ 38.89M$ 36.20M$ 53.80M
Net Non Operating Interest Income Expense
$ -18.80M$ -13.39M$ -13.89M$ -22.15M$ 0.00$ 0.00
Other Income Expense
$ -222.82M$ 1.02M$ -3.53M$ -39.78M$ -25.02M$ -17.00M
Pretax Income
$ -244.35M$ -198.75M$ 48.27M$ -23.04M$ 11.18M$ 36.80M
Tax Provision
$ 113.29M$ 112.08M$ 2.38M$ -4.72M$ -89.08M$ 30.92M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -357.64M$ -310.83M$ 45.89M$ -18.32M$ 100.27M$ 5.88M
Basic EPS
$ -9.07$ -7.93$ 1.22$ -0.50$ 2.76$ 0.16
Diluted EPS
$ -9.07$ -7.93$ 1.17$ -0.50$ 2.76$ 0.16
Basic Average Shares
$ 158.90M$ 39.19M$ 37.75M$ 36.43M$ 36.39M$ 36.39M
Diluted Average Shares
$ 158.90M$ 39.19M$ 39.29M$ 36.43M$ 36.39M$ 36.39M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
$ -0.14-$ 2.53$ 1.68--
Rent Expense Supplemental
Total Expenses
$ 130.23M$ -512.24M$ 321.50M$ 292.08M$ 267.12M$ 223.19M
Net Income From Continuing And Discontinued Operation
$ -357.64M$ -310.83M$ 45.89M$ -18.32M$ 100.27M$ 5.88M
Normalized Income
$ -115.05M-$ 50.74M$ -5.23M$ 118.77M$ 18.25M
Interest Expense
$ 7.61M-$ 14.00M$ 22.74M$ 0.00$ 0.00
$ -224.72M$ -185.36M$ 62.27M$ -303.00K$ 11.18M$ 36.80M
$ -196.22M$ -182.38M$ 91.93M$ 29.74M$ 40.03M$ 62.56M
Currency in USD

Cerence Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis